-Bloomberg
Regeneron’s Prostate Cancer Combo Candidate Shows Encouraging Anti-Tumor Activity
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) earned $9.77 per share for Q2 FY22, down 62% Y/Y, beating the $9.54 estimate. Sales decreased…
Related Posts
Court Rules In Favor Of AstraZeneca Over Delay In COVID-19 Shot Deliveries
AstraZeneca Plc (NASDAQ:AZN) claims victory in a court tussle with the European Union over allegations that the company was not producing…
Honest Company Shares Soar Following Launch On Walmart
Honest Company Inc (NASDAQ:HNST), known as the go-to clean, conscious lifestyle brand, launched in 2012 by Jessica Alba, has expanded…
If You Invested $1,000 In Donald Trump NFTs, Here’s How Much You Would Have Now
Former President Donald Trump made headlines in late 2022 when he revealed a non-fungible token collection. The NFTs were widely criticized, but also saw huge demand from fans and collectors.
Here’s how much an investment in the NFTs would be worth today.